Subscribe to our blog and we'll email you the new articles we publish.
Subscribe to the newsletter
Table of Contents
The pharmaceutical sector faces unique challenges in wastewater treatment due to the nature of the compounds found in the effluents generated during drug manufacturing.
Active compounds such as antibiotics and commonly used pharmaceuticals, like paracetamol and ibuprofen, make water treatment a a complex and crucial task for environmental sustainability.
This often causes the Traditional treatment methods need to be reinforced with other alternatives to eliminate these contaminants. effectively, which has led the sector to seek more advanced solutions.
In this context, technologies such as systems of Moving Bed Biofilm Reactor (MBBR) y Membrane Bioreactors (MBR) They have emerged as cutting-edge options that offer efficient treatment of pharmaceutical wastewater.
Contaminants to be treated in the pharmaceutical sector
In the pharmaceutical sector, wastewater generated during the manufacture of medicines contains a variety of specific contaminants that require specialized treatment.
The main pollutants include:
Easily biodegradable organic matter
A large fraction of the organic matter present in pharmaceutical wastewater is readily biodegradable, such as alcohols and ketones.
Inhibitory and toxic compounds (Antibiotics)
Antibiotics and other inhibitory and toxic compounds pose a challenge in wastewater treatment, as they can affect the microbiology of purification systems.
Slowly biodegradable organic compounds
Some compounds, such as chlorinated hydrocarbons and refractory substances, are difficult to break down, requiring advanced technologies for their disposal.
Soaps and detergents with surfactants
Soaps and detergents used in pharmaceutical production contain surfactants that can affect water quality if not disposed of properly.
How to treat industrial wastewater in the pharmaceutical sector?
Wastewater treatment in the pharmaceutical industry presents unique challenges due to the complex nature of the effluents generated during drug production.
These effluents may contain active pharmaceutical ingredients, intermediate products and other compounds difficult to remove with traditional depuration methods.
To address this problem, advanced technologies are required that not only effectively remove pollutants, but also comply with strict environmental regulations.
Technologies like Moving Bed Biofilm Reactor (MBBR) and the Membrane Bioreactor (MBR) They have become key options for treating wastewater in this sector, providing efficient and adaptable solutions to existing infrastructures.
These systems not only improve the quality of treated water, but also optimize the space and resources of the facilities.
MBBR and MBR: Key technologies for water treatment in the pharmaceutical industry
MBBR and MBR are being increasingly implemented in the pharmaceutical industry due to their ability to treat wastewater with high concentrations of difficult-to-remove compounds.
These technologies not only do they improve water quality treated, but also They optimize production processesThis allows companies to comply with environmental regulations and improve their operational efficiency.
Technology MBBR It has stood out for its ability to adapt to existing infrastructures, allowing pharmaceutical companies to improve their processes without the need for major structural modifications.
This system is used to remove organic substances, reducing the pollutant load and allowing for more effective treatment, even in confined spaces.
Furthermore, the MBR It combines advanced biological treatment with a membrane separation system, ensuring the removal of suspended solids and other dissolved organic compounds.
This makes the MBR an ideal solution for the safe reuse of treated water in various industrial processes.
Success stories and results
Pharmaceutical companies that have implemented these technologies have experienced significant improvements in wastewater treatment.
A success story from the pharmaceutical industry It demonstrates how the implementation of MBBR allowed for increased treatment capacity in a limited space.While a The MBR system applied in the production of hygiene products successfully met environmental regulations without compromising operational efficiency.
Estos son los de algunos Benefits we offer to ensure efficient wastewater management:
- We eliminate suspended solidsWe take care of the complete removal of fibers and large particles using a effective pretreatment and high-tech membranes.
- We reduced the CODWe significantly reduce the organic load of the water using a combination of biological processes and advanced oxidation.
- We comply with the regulationsWe guarantee the production of a superior quality effluent, complying with the strictest legal and regulatory requirements.
- We optimized the processWe are continuously improving the treatment system without interrupting daily operations. plantensuring efficiency and sustainability.
At SITRA we develop ➡️engineering, operation and maintenance solutions.
Do you need more information about us? Call us!
